CORC

在结果中检索

CORC

浏览/检索结果: 共213条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Development and validation of a radiomics-based method for macrovascular invasion prediction in hepatocellular carcinoma with prognostic implication 会议论文
美国圣地亚哥, 2019年2月20日
作者:  Wei Jingwei;  Fu Sirui;  Zhang Shuaitong;  Zhang Jie;  Gu Dongsheng
收藏  |  浏览/下载：73/0  |  提交时间：2019/05/08
Risk Factors Related to the Development of Post Stroke Cognitive Impairment in Shanghai Stroke Population 会议论文
作者:  Dong Yi;  Cui Mei;  Fang Min;  Gong Li;  Wang Xiuzhe
收藏  |  浏览/下载：55/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：43/0  |  提交时间：2019/12/05
The study of running stability of piggyback car based on a Fe-rigid coupled model 会议论文
12th International Workshop on Structural Health Monitoring: Enabling Intelligent Life-Cycle Health Management for Industry Internet of Things (IIOT), IWSHM 2019, Stanford, CA, United states, 2019-09-10
作者:  Xiaoxue, Liu;  Hanfei, Guo;  Suming, Xie;  Weidong, He;  Xiaofeng, Li
收藏  |  浏览/下载：18/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
Calculation of Induced Voltage and Current on a Crossing Transmission Line under UHV AC Transmission Lines 会议论文
作者:  Yuze, Li;  Xiaofeng, Kong;  Bo, Zhang
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Query Associations Over Big Financial Knowledge Graph 会议论文
作者:  Ouyang, Xiaofeng;  Hong, Liang;  Zhang, Lujia
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace